ESTA · Establishment Labs Holdings Inc.
$83.07
-8.19 (-8.97%)
At close · Aug 6
Earnings today
Market Cap
$2.69B
Shares
29.43M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$91.25
Open$93.57
Day$90.87–96.62
52W$33.35–97.59
Avg vol 30d695K
Short int4.5M · 15.2% float · 8.5d
Short vol35%
Last earningsAug 6, 2026
DataJan 2020–Aug 2026
Filing10-Q · May 8
Up next
Earnings call today
Aug 6, 2026
Today
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 8, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.46
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+28%
above
Price vs 50-day avg
+7%
above
RSI (14)
53
neutral
MACD trend
Negative
52-week position
90%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+4%
trailing
6-month return
+25%
trailing
YTD return
+25%
this year
Relative strength
+14%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $86 › 200d $71 — 50d above 200d
Institutional flow
Accumulating
48 of 178 funds reported for Jun 30 · net +189.9K sh shares · +12 new
Insider flow
Distributing
Net -$8.1M over 90 days · 100% sells
Short interest
Falling
15.24% of float · ▼ -6.0% MoM · 8.5 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
178 holders — near 3-yr high, broad support
Squeeze score
92
high risk · 0–100
Fundamentals
Revenue growth
+76%
Y/Y
Gross margin
239%
contracting
EPS growth
+43%
Y/Y
Free cash flow
$-56.9M
Balance sheet
$172.0M
net debt
Quant / Vol
risk profile
Volatility
58%
annualized · 1-yr
Max drawdown
−31%
past year
ATR
4.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 6, 2026
Revenue
· Fiscal 2026
Maintained
$266.5M – $268.5M
prior FY $211.08M
midpoint +26.7% Y/Y
Guided vs delivered
· last 2 settled
2025 revenue
2025
guided at least $210M
$211.08M
In line
US sales
first quarter 2025
guided $5.5M
$41.38M
Beat +652.3%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+28%
Bullish
Price vs 50-day avg
+7%
Bullish
RSI (14)
53
Neutral
MACD trend
Negative
Bearish
52-week position
90%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $86 › 200d $71 — 50d above 200d
Institutional flow
Accumulating
48 of 178 funds reported for Jun 30 · net +189.9K sh shares · +12 new
Insider flow
Distributing
Net -$8.1M over 90 days · 100% sells
Short interest
Falling
15.24% of float · ▼ -6.0% MoM · 8.5 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
178 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $33
Now $91 · 90%
52-wk high $98
vs 200-day avg +28%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $3.7M | second quarter ended June 30, 2026 | — |
|
|
|||
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ESTA
this stock
Establishment Labs Holdings Inc.
|
$2.69B | +25.2% | +2.1% | — | 15.2% |
|
ABT
Abbott Laboratories
|
$184.13B | -14.1% | +5.7% | 29.6 | 1.4% |
|
SYK
Stryker Corp
|
$129.28B | -3.6% | +11.2% | 34.9 | 1.8% |
|
MDT
Medtronic plc
|
$110.07B | -8.9% | +8.4% | 23.1 | 1.5% |
|
BSX
Boston Scientific Corp
|
$69.19B | -49.9% | +5.5% | 19.3 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ESTA | -0.7% | +3.7% | +25.5% | -1.4% | +25.2% |
| SPY | +5.5% | +3.3% | +11.3% | +3.1% | +12.9% |
| vs SPY | -6.3% | +0.4% | +14.2% | -4.4% | +12.3% |
Key facts
CIK
1688757
CUSIP
G31249108
13F (30d)
42 filings
42 filers
Visit website
Investor relations